Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
1,986,053
-
Shares change
-
+116,761
-
Total reported value, excl. options
-
$7,567,000
-
Value change
-
+$563,572
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$3.81
Significant Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q1 2021
9 filings reported holding ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share as of Q1 2021.
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,986,053 shares
of 45,504,462 outstanding shares and own 4.36% of the company stock.
Largest 9 shareholders include Knoll Capital Management, LLC (1,791,363 shares), RENAISSANCE TECHNOLOGIES LLC (120,407 shares), MILLENNIUM MANAGEMENT LLC (38,611 shares), Tower Research Capital LLC (TRC) (21,999 shares), XTX Topco Ltd (11,559 shares), UBS Group AG (1,614 shares), Clearstead Advisors, LLC (500 shares), Virtu Financial LLC (0 shares), and Phoenix Holdings Ltd. (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.